|
SCRN1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.59450000001027E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.92769999999887E-05 |
| Normal-vs-Stage2 |
1.195820E-01 |
| Normal-vs-Stage3 |
3.997500E-04 |
| Normal-vs-Stage4 |
9.065000E-03 |
| Stage1-vs-Stage2 |
4.818000E-01 |
| Stage1-vs-Stage3 |
6.595200E-01 |
| Stage1-vs-Stage4 |
9.952600E-01 |
| Stage2-vs-Stage3 |
3.406600E-01 |
| Stage2-vs-Stage4 |
5.486600E-01 |
| Stage3-vs-Stage4 |
7.525000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.7753099999962E-05 |
| Normal-vs-AfricanAmerican |
1.125910E-02 |
| Normal-vs-Asian |
9.299300E-03 |
| Caucasian-vs-AfricanAmerican |
3.098400E-01 |
| Caucasian-vs-Asian |
6.945200E-01 |
| AfricanAmerican-vs-Asian |
5.698600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.055800E-02 |
| Normal-vs-Female |
1.38880000000174E-06 |
| Male-vs-Female |
5.906200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.74941999999678E-05 |
| Normal-vs-Age(41-60Yrs) |
1.436940E-03 |
| Normal-vs-Age(61-80Yrs) |
8.283000E-03 |
| Normal-vs-Age(81-100Yrs) |
3.757200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.368630E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.270400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.655200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.879800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.858400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.904400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.110200E-01 |
| Classical-VS-Follicular |
1.43620000003786E-06 |
| Classical-VS-Other |
2.350400E-01 |
| Classical-VS-Normal |
2.08399999479525E-08 |
| Tall-VS-Follicular |
1.521760E-03 |
| Tall-VS-Other |
1.531230E-01 |
| Tall-VS-Normal |
1.280080E-03 |
| Follicular-VS-Other |
7.001200E-01 |
| Follicular-VS-Normal |
7.372200E-01 |
| Other-VS-Normal |
6.213800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.954270E-02 |
| Normal-vs-N1 |
2.748000E-02 |
| N0-vs-N1 |
4.353000E-01 |
|
|
